Access cutting-edge schizophrenia treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.
Access schizophrenia specialists in Baltimore at no cost
This study follows strict safety protocols and ethical guidelines
All study-related schizophrenia treatment provided free
Two-hundred and eighty individuals with schizophrenia who have a recent history of violent acts will be randomized in this 2-arm, parallel-group, 24-week, open-label, 7-site clinical trial to examine the effects of treatment with clozapine vs antipsychotic treatment as usual (TAU) for reducing the risk of violent acts in real-world settings
Sponsor: New York State Psychiatric Institute
Check if you qualify for this schizophrenia clinical trial in Baltimore, MD
If you're searching for schizophrenia treatment options in Baltimore, MD, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced schizophrenia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.